Jazz Pharmaceuticals (NYSE: JAZZ) made a little noise in Palo Alto after the Ireland-based biopharmaceutical company signed a lease with Stanford University to fully occupy a planned 99,415-square-foot office project set to break ground later this year at 3181 Porter Dr.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In